key: cord-0735912-djou1kms authors: Kadoya, Yoshihiko; Watanapongvanich, Somtip; Yuktadatta, Pattaphol; Putthinun, Pongpat; Lartey, Stella T.; Khan, Mostafa Saidur Rahim title: Willing or Hesitant? A Socioeconomic Study on the Potential Acceptance of COVID-19 Vaccine in Japan date: 2021-05-02 journal: Int J Environ Res Public Health DOI: 10.3390/ijerph18094864 sha: 19fc61bbefc3622dbdbca06880dbef000985b792 doc_id: 735912 cord_uid: djou1kms The worldwide COVID-19 vaccination program is already underway, raising hopes and aspirations to contain the spread of the COVID-19 pandemic that halted economic and social activities. However, the issue of vaccine effectiveness and its side-effects is influencing the potential acceptance of vaccines. In this uncertain situation, we used data from a nationwide survey in Japan during February 2021, following the Japanese government’s initial phase of COVID-19 vaccination. Our results show that 47% of the respondents are willing to take a vaccine once it is available, while 22% are not willing and another 31% remain indecisive. Our ordered probit regression results show that demographic, socioeconomic, and behavioral variables such as gender, age, subjective health status, children, household income, household assets, financial literacy, future anxiety, and myopic view of the future are associated with willingness to take a COVID-19 vaccine. Our findings suggest that Japan’s government should not adopt a one-size-fits-all policy to promote the vaccination program, but rather target people with specific socioeconomic backgrounds who are less willing and more hesitant to take a vaccine. The current novel coronavirus disease (COVID-19) is highly contagious. As of 18 March 2021-a year after the WHO categorized the COVID-19 outbreak as a pandemic, there were 120,915,219 cumulative cases and 2,674,078 total deaths [1] . The number of infected cases is believed to be underreported because of asymptomatic infection, hesitancy to get tested, and lack of alternative testing procedures [2] [3] [4] [5] . The pandemic disrupted many aspects of human activity, leading to worldwide economic challenges including increased unemployment, income, food, and housing insecurity, and intimate partner violence [6] [7] [8] . In response to the crisis and to bring human activity closer to normal, institutions implemented several preventive measures, in addition to the swift development of several vaccines-with this being the fastest vaccine development in history [9, 10] . Although achieving herd immunity through vaccination is considered vital in reducing the spread of COVID-19 and restoring normalcy in human activities, public perceptions of COVID-19 vaccines are still mixed [11] [12] [13] [14] [15] . These perceptions will likely affect the willingness to receive the vaccines, lead to lower vaccination rates, and put the unvaccinatable vulnerable groups at greater risk. Previous studies show that public willingness to receive a COVID-19 vaccine varies worldwide and over time. Lazarus et al. conducted a survey in June 2020 and found that, if the vaccines are proven to be safe and effective, 75.4% of respondents in the US, and 54.8% to 88.6% of respondents worldwide are willing to be vaccinated [12] . In Our study uses panel data from the Household Behavioral and Financial Survey funded by Hiroshima University's Hiroshima Institute of Health Economics Research (HiHER). The panel survey was conducted by Nikkei Research, a leading research company in Japan. Nikkei Research's database is one of the largest in the country and representative of Japanese population from all socioeconomic backgrounds. The first online survey was conducted around the beginning of the COVID-19 pandemic from 20-25 February 2020 using a random sampling procedure. A year later, the second online survey was conducted around the beginning of the COVID-19 vaccination program in Japan from 19-26 February 2021 and targeted individuals who responded to the 2020 survey. The datasets consist of information on socioeconomic characteristics and preferences for the population in Japan aged 20 and above. It had 17,463 and 6103 total observations in 2020 and 2021, respectively. We utilized the 2021 dataset, which contains respondents' socioeconomic status and questions regarding willingness to receive COVID-19 vaccination. Additionally, we used demographic characteristics and preferences, including gender, age, education, place of residence, children in the household, and financial literacy from the 2020 dataset. Our final sample consisted of 4253 observations or approximately 70% of total observations in the 2021 dataset. Regrettably, we had to exclude 1850 observations due to missing data on important socioeconomic variables such as household income and household assets. Our dependent variables "willingness to take vaccine" and "vaccine hesitancy" were based on the 2021 survey's item "Once the COVID-19 vaccine becomes available free of charge, I will take it soon" rated on the five-point scale described in detail in Table 1 . We treated "willingness to take vaccine" as an ordinal variable on the basis of the above item and "vaccine hesitancy" as a binary variable following Fisher et al. [20] . Willingness to take vaccine Ordinal variable: 1 = It does not hold true at all for you; 2 = It is not so true for you; 3 = It is either true or not true; 4 = It is rather true for you; 5 = It is particularly true for you for the statement "Once the Covid-19 vaccination becomes available with free of charge, I will take it soon." Vaccine hesitancy Binary variable: 1 = Respondent selected 1, 2, or 3 for the statement "Once the Covid-19 vaccination becomes available with free of charge, I will take it soon," and 0 = Otherwise. For the explanatory variables, we included gender, age, education, place of residence, marital status, children in the household, living situation, employment status, household income, and household assets as demographic variables. We also included financial literacy as a proxy for rational decision-making ability in health-related behaviors, as suggested by [47] [48] [49] [50] [51] . Furthermore, we included subjective health status, future anxiety, risk preference, and myopic view of the future. Table 1 provides the definitions of all the variables. Table 2 presents the descriptive statistics of the sample, which contained 4253 observations. The average score of willingness to take vaccine was 3.41 out of 5. Additionally, 53% of the sample exhibited some vaccine hesitancy. To provide further detail, Tables 3 and 4 present the distribution of the willingness to take vaccine and vaccine hesitancy variables classified by age group. The results in Table 3 show that, overall, most of the respondents (1333 observations or 31.34% of the total sample) answered 3 for the statement "Once the COVID-19 vaccination becomes available with free of charge, I will take it soon", followed by 5 at 25.11%, 4 at 21.51%, 2 at 13.28%, and 1 at 8.75%. If we divide the sample into five age groups, the majority of respondents in each age group answered 3 except the respondents in oldest age group, who answered 5, implying that they are the most willing to take the vaccine (37.68% of the sample in the oldest age group). The results in Table 4 for vaccine hesitancy show that the vaccine hesitancy rate was highest in respondents aged 31-40 and tended to decrease as the respondents became older-from 62.32% in the sample aged 31-40 to 35.75% in the sample aged 61 and above. For the demographic variables, Table 2 shows that about 65% of respondents were men and the average age was 50.32 years. Approximately 62% of the sample held a university degree and 61% of the sample lived in a central area (around the Tokyo or Osaka metropolitan areas). For household status, 66% of the sample were married, 57% had children, and 20% lived alone. About 64% of the respondents were employed. Respondents had annual household incomes of approximately 6.34 million JPY on average and 19.80 million JPY in household assets in 2021. The average financial literacy score was 0.65; that is, they could answer wo out of the three financial literacy questions correctly. On average, respondents rated their subjective health status, future anxiety, and myopic view of the future at 3.24, 3.71, and 2.69, respectively, out of 5. Overall, the respondents had risk preferences of 46%; in other words, they were slightly risk-averse. We explored the association between socioeconomic factors and respondents' willingness to take vaccine and vaccine hesitancy using Equations (1) and (2), respectively. where Y 1 is willingness to take vaccine, Y 2 is vaccine hesitancy, X is a vector of individual characteristics, and ε is the error term. We used an ordered probit (oprobit) regression to estimate Equation (1), as the dependent variable was an ordinal variable, and a probit regression to estimate Equation (2), as the dependent variable was a binary variable. Since the probit model estimates the probability of an observation to fall into one of the specified categories, we believed that probit models were suitable to predict the probability of willingness (or hesitancy) of respondents to take COVID-19 vaccine. As there was potential multicollinearity between the explanatory variables in the models (i.e., individuals with a high level of education could have high financial literacy), we conducted correlation and multicollinearity tests in all models (provided as Supplementary Materials). The correlation matrix showed a weak relationship between the explanatory variables (lower than 0.70). In addition, the variance inflation factor tests of the explanatory variables were below 10, indicating that multicollinearity was not significant in all models. Equations (3) and (4) provide the full model specifications of Equations (1) and (2), respectively. Willingness to take vaccine i = β 0 + β 1 male i + β 2 age i + β 3 age squared i + β 4 university degree i + β 5 live in central area i + β 6 marriage i + β 7 children i + β 8 live alone i + β 9 employed i + β 10 log o f household income i + β 11 log o f household assets i + β 12 f inancial literacy i + β 13 subjective health i + β 14 f uture anxiety i + β 15 level o f risk pre f erence i + β 16 myopic view o f the f uture i + ε i . (3) We first report the results of the full sample analysis in Section 3.1. In Tables 5 and 6 , we report the results when using the willingness to take vaccine and vaccine hesitancy as the dependent variables, respectively. We then performed the same analysis after dividing the sample by age and gender in Sections 3.2 and 3.3, respectively. Each table below presents the results of four specifications of the explanatory variables. The first specification includes controls for only the demographic variables. In the second specification, we added financial variables including household income, household assets, and financial literary. The third specification includes respondents' subjective health status and future anxiety ratings. Lastly, the fourth specification includes respondents' risk preferences and myopic views of the future. Note: Robust standard errors are in parentheses; *** p < 0.01, ** p < 0.05, * p < 0.1. In Table 5 , the ordered probit model regression results show that male, age squared, university degree, having children, employment, log of household income, log of household assets, financial literacy, subjective health status, and future anxiety had a positive and significant impact on the willingness to take vaccine across the models (except for university degree, employment, and log of household assets, which showed a significant impact in some models). In contrast, only one variable, age, showed a negative and strongly significant impact on the willingness to take vaccine across the models. In Table 6 , in which we used vaccine hesitancy as the dependent variable, the results from the probit model regression were consistent with the results in Table 5 . Most of the variables that showed a significant impact in Table 5 also showed a significant impact in Table 6 , albeit in opposite directions. In Table 6 , male, age squared, children, log of household assets, financial literacy, subjective health status, and future anxiety had negative and strongly significant impacts, whilst age had a positive and strongly significant impact on vaccine hesitancy in the final specification (Model 2.4). In addition to the results in Table 5 , level of risk preference showed a positive and weakly significant impact at the 10% level on vaccine hesitancy in Model 2.4. Figures 1 and 2 show that age had a nonlinear relationship with willingness to take vaccine and vaccine hesitancy; hence, we further explored the impact of age in the subsample analysis. We divide the respondents by age into two groups, respondents aged under 65 and respondents aged 65 and above, and we applied the same estimation methods. Table 7 reports the results from the ordered probit model regression and Table 8 shows the results from the probit model regression. Figures 1 and 2 show that age had a nonlinear relationship with willingness to take vaccine and vaccine hesitancy; hence, we further explored the impact of age in the subsample analysis. We divide the respondents by age into two groups, respondents aged under 65 and respondents aged 65 and above, and we applied the same estimation methods. Table 7 reports the results from the ordered probit model regression and Table 8 shows the results from the probit model regression. The results in Tables 7 and 8 show that, overall, there were no differences in the significance of the estimated parameters compared to the results in Tables 5 and 6. Most of the coefficients had consistent signs and significance levels across models and specifications, except the myopic view of the future variable, which became significant in Table 7 The results in Tables 7 and 8 show that, overall, there were no differences in the significance of the estimated parameters compared to the results in Tables 5 and 6. Most of the coefficients had consistent signs and significance levels across models and specifications, except the myopic view of the future variable, which became significant in Table 7 compared to Table 5 indicate that only being male, having children, and the log of household assets still had a significant impact on the willingness to take vaccine (positive coefficients) and vaccine hesitancy (negative coefficients). The results of full sample analysis in Tables 5 and 6 indicated that male respondents were more willing to take vaccine and exhibited less vaccine hesitancy. Therefore, we further explored the impact of gender in the subsample analysis and report the results in Tables 9 and 10. Overall, the results in Tables 9 and 10 were similar to the full sample analysis in Tables 5 and 6. The age, age squared, children, and subjective health variables showed significant effects on the willingness to take vaccine and vaccine hesitancy in both the male and the female subsamples in Tables 9 and 10 . Comparing the male and female subsamples, the log of household assets, financial literacy, future anxiety, and myopic view of the future had significant impacts in the male subsample (Models 8. Our findings show that willingness to take vaccine and vaccine hesitancy in Japan changed over time. Yoda and Katsuyama [23] and Machida et al. [33] reported that 65.7% and 62.1% of Japanese were willing to be vaccinated and that 34.27% and 37.9% were hesitant or would refuse vaccination, respectively. After the vaccination program's deployment in Japan from February 2021, 46.62% of Japanese were willing to be vaccinated (Table 3) . Approximately 53% were hesitant or would refuse vaccination (Table 4 ). These changes may support our conjecture that news about the vaccines affects the Japanese people's attitudes toward vaccination, as mentioned earlier. We obtained several significant findings from the full model specification (Model 1.4 in Table 5 and Model 2.4 in Table 6 ), some of which are consistent with prior studies in Japan [23, 33] , while others are not. The effects of gender, for example, are similar to those reported in [23, 33] . We found that men had a higher willingness and were less hesitant to receive vaccination than women. This hesitancy stems from women's concerns over the COVID-19 vaccine's potential side-effects, as presented in [23] . This concern among women also may be linked to earlier safety concerns in Japan over other vaccines such as the human papillomavirus (HPV) vaccine [39] . Prior studies also found similar results before the deployment of mass vaccination programs in other countries [17, 52, 53] . On the other hand, the effects of age, subjective health status, and having/not having children are inconsistent with other studies. Machida et al. [33] found that older people or those with health conditions were more willing to receive vaccination. However, our findings indicate that older working-age people (Tables 7 and 8 ) and those with low subjective health status (Tables 5 and 6 ) were less willing and were more hesitant to receive the vaccination [33] . As negative news regarding vaccine safety in Japan and other countries is resurfacing [30, 31, 54] , these people may have concerns about the potential side-effects and their capability of withstanding such effects. Although some recipients may experience moderate side-effects, they may take some time to recover [54] [55] [56] [57] [58] [59] . As the older working-age people may have higher expected opportunity costs due to greater jobrelated responsibilities, they may be more hesitant to receive the vaccination. Consequently, the government should implement intervention policies that target females, the older working-age population, and those with low subjective health status. Additionally, we found that some household, financial status, and behavioral variables influenced vaccination attitudes. First, having children had a significant positive association with people's willingness to receive vaccination and a significantly negatively association with vaccine hesitancy. These findings may suggest that having children provides meaning in people's lives or a sense of responsibility and accountability. Thus, these people may be more willing to receive vaccination. Because of these significant effects of having children, further studies should explore children's characteristics in detail, such as age, number of children in the household, and so on, as they may influence attitudes toward COVID-19 vaccination. Second, we found that financial status variables such as household income, household assets, and financial literacy significantly affect attitudes toward COVID-19 vaccination. Our findings on the income effect are consistent with other studies in Japan [33] and in other countries [12, 60] . Regardless, due to the insignificant relationship between household income and vaccine hesitancy, we argue that the government should not implement policies targeting people in low-income households. The government should instead enact policies targeting people living in households with low asset value, as our findings indicate that households with more assets were more willing to receive vaccination and were less likely to be hesitant toward vaccination. The government should also introduce financial literacy improvement policies, as we found that people with better financial literacy were less likely to have vaccine hesitancy. This finding is consistent with other studies reporting that financial literacy discourages irrational behaviors [49] [50] [51] and is positively associated with health literacy [61] . Lastly, we found that behavioral variables such as future anxiety and a myopic view of the future affected attitudes toward vaccination. Intrinsically, people with anxiety are risk-averse; they prefer anticipated risk to unanticipated risk. Since it is easier to anticipate the risk of COVID-19 vaccination than to anticipate the risk of COVID-19 infection, we found that people with anxiety about the future were more willing to receive vaccination and were less likely to be hesitant. Meanwhile, people with a myopic view of the future may not calculate risks. We found that they were more likely to have vaccine hesitancy. Overall, our findings that people with certain demographic, socioeconomic, and psychological backgrounds were hesitant to take the COVID-19 vaccine has important policy implications. Since the government must achieve herd immunity, it must demonstrate that the risk of COVID-19 infection is greater than the risk of COVID-19 vaccination. Chou and Budenz [62] emphasized on the evidence-based communication strategies taking peoples' emotion into considerations to address vaccine hesitancy and foster vaccine confidence. The government may also need to establish a more effective public dialogue to ensure a general understanding of the COVID-19 situation. However, findings of this study should be generalized cautiously for other countries. Since willingness or hesitancy to take vaccine depends on several factors including behavioral and social aspects, the contributing factors could differ country-wise. This study had some limitations. Since there is an unequal household income distribution in the internet penetration rate [63] , our survey respondents may live in households with a higher income than the average Japanese household. However, the Statistics Bureau found that the average Japanese household income (before tax) is 535,392 JPY per month or 6.42 million JPY per year [64] . This is slightly higher than our sample average income (6.34 million yen per year). Additionally, the average age and gender ratios of our sample differ from the national statistics [65] . We also excluded observations because some respondents decided not to provide sensitive data such as household income and household assets. Nevertheless, our study provides robust and consistent evidence on the willingness to receive vaccination after the vaccine rollout began in Japan. The COVID-19 pandemic had unprecedented effects on all aspects of life. Most countries have already started vaccination programs to contain the effects of the pandemic and to restore some normalcy to human life. However, several incidents of side-effects and the issue of vaccine effectiveness have possibly affected public acceptance of the COVID-19 vaccines. In this situation, we conducted a study to examine Japanese peoples' willingness to take one of the vaccines using a nationwide survey in Japan in February 2021. The sample period follows the Japanese government's initial phase of the COVID-19 vaccination program. Our investigation showed that Japanese people were moderately willing to take a vaccine; 47% of the respondents were willing to take a vaccine once it is available, while 22% of respondents were unwilling and another 31% of respondents remained indecisive. The results further implied that 53% of respondents were hesitant to take one of the vaccines, which would be a significant enough proportion of the population to make health authorities concerned about the perceived success of the vaccination program. Comparing our results with those of previous studies seems to suggest that the willingness to receive vaccination and vaccine hesitancy vary over time. Although previous studies [23, 33] suggested that some characteristics influence the willingness to receive vaccination and vaccine hesitancy, our findings suggest somewhat different implications. As negative news about the vaccines emerged in Japan, we found that people became less willing to receive a vaccination and became more hesitant. Our estimations showed that variables such as gender, age, subjective health status, children, household income, household assets, financial literacy, future anxiety, and myopic view of the future were associated with willingness to take a COVID-19 vaccine. Because the factors associated with the willingness to take a vaccine seem to evolve over time, the Japanese government should consider the findings of our study while implementing vaccination programs, as well as for other intervention policies. Moreover, previous studies found a link between COVID-19 vaccine hesitancy and other vaccine hesitancy [23, 33, 39] , providing grounds for a more rigorous understanding of COVID-19 vaccine hesitancy. Prior experience suggests that any negative media coverage on COVID-19 vaccines can lead to persistent vaccine hesitancy, leading to more substantial vaccine refusal in Japan. Thus, the government should target specific hesitant groups and devise appropriate motivational programs. Supplementary Materials: The following are available online at https://www.mdpi.com/article/10 .3390/ijerph18094864/s1. Table S1 : Correlation matrix. WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus Disease (COVID-19) Using artificial neural network with prey predator algorithm for prediction of the COVID-19: The case of Brazil and Mexico Unveiling COVID-19 from CHEST X-ray with deep learning: A hurdles race with small data Transfer-to-transfer learning approach for computer aided detection of COVID-19 in chest radiographs COVID-19 detection from chest X-ray images using feature fusion and deep learning A pandemic within a pandemic-Intimate partner violence during Covid-19 COVID-19 and people experiencing homelessness: Challenges and mitigation strategies Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships The Fastest Vaccine in History. UCLA Health Vaccine: How Did They Make It So Quickly? BBC News Willingness to get the COVID-19 vaccine with and without emergency use authorization El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications Intent to Get a COVID-19 Vaccine Rises to 60% as Confidence in Research and Development Process Increases Growing Share of Americans Say They Plan to Get a COVID-19 Vaccine-or Already Have COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates COVID-19 vaccination acceptance and its associated factors among a middle eastern population. Front. Public Health Correlates and disparities of intention to vaccinate against COVID-19 Vaccine hesitancy: The next challenge in the fight against COVID-19 Attitudes toward a potential SARS-CoV-2 vaccine: A survey of US adults COVID-19 vaccine hesitancy in the UK: The Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II Can a COVID-19 vaccine live up to Americans' expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions Willingness to receive COVID-19 vaccination in Japan Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other arab countries Covid in Europe: Vaccine Suspension Hits Rollout as Cases Rise Vaccine Controversies: What You Need to Know as Germany, Italy and France Suspend Use Covid-19: Why Countries Are Suspending AstraZeneca Vaccinations Fact-Checking Detroit Mayor's Misleading Statements on Johnson & Johnson Vaccine-CNNPolitics Covid-19 Vaccine Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots Covid-19 Vaccine: First Person Receives Pfizer Jab in UK Is the Coronavirus Vaccine Safe? NHK WORLD Issues Anaphylaxis Warning on Pfizer Vaccine after Adverse Reactions. The Japan Times Reports 12 More Anaphylaxis Cases. NHK WORLD Case of Hives Reported in One Patient Following COVID-19 Vaccination in Japan. The Japan Times Reports First Anaphylactic Reaction from Coronavirus Vaccine. The Japan Times Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: A large-scale retrospective temporal modelling study Willingness to vaccinate against COVID-19 in Australia Predicting Willingness to Vaccinate for COVID-19 in the US Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey A national survey assessing SARS-CoV-2 vaccination intentions: Implications for future public health communication efforts Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants Pfizer Ends COVID-19 Trial with 95% Efficacy, to Seek Emergency-Use Authorization Largest Batch of Vaccines Arrives in Japan. NHK WORLD Can financial literacy reduce anxiety about life in old age? Financial literacy and anxiety about life in old age: Evidence from the USA Do financial literacy and financial education influence smoking behavior in the United States? Financial literacy, financial education, and smoking behavior: Evidence from Japan. Front. Public Health COVID-19 vaccination hesitancy in the United States: A rapid national assessment COVID-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics Normal' to Feel a Bit Unwell after Covid Vaccine Information about the Pfizer-BioNTech COVID-19 Vaccine Covid Vaccine Side-Effects: What Are They, Who Gets Them and Why? The Guardian No populations left behind: Vaccine hesitancy and equitable diffusion of effective COVID-19 vaccines Workers with COVID-19 Vaccine Side Effects Deserve Time off to Recover Vaccine After Effects More Common in Those Who Already Had COVID. COVID Symptom Study Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey The impact of health and financial literacy on decision making in communitybased older adults Considering emotion in COVID-19 vaccine communication: Addressing vaccine hesitancy and fostering vaccine confidence Communications Usage Trend Survey in 2019 Compiled Statistics Bureau. Japan Statistical Yearbook The authors declare no conflict of interest.